ClinicaliQ Trial Snapshot
- Innovative Ovarian Cancer Biomarker Assays — Recruiting • Oncology • NCT07693894.
- What is being tested: Blood-based biomarker assays designed to detect ovarian cancer earlier through analysis of circulating tumour markers and related biological indicators, offering a potential alternative to traditional diagnostic methods.
- Patient eligibility overview: The trial typically includes women with suspected ovarian cancer symptoms, asymptomatic high-risk individuals (including BRCA mutation carriers), and control groups without ovarian cancer to establish diagnostic accuracy and clinical utility.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Ovarian cancer is often diagnosed at a later stage because early symptoms can be mild or non-specific. Earlier detection of ovarian cancer could improve treatment options and outcomes. Recent research has focused on the development of blood-based tests, sometimes referred to as liquid biopsy tests, which aim to look for changes in the blood that could be linked to cancer. These tests are still under investigation and are not part of routine clinical care. The purpose of this study is to evaluate several blood-based ovarian cancer tests. This will be…
Eligibility Snapshot
- : EOC patients 1. Women, trans men and non-binary people with female reproductive organs 2. Aged ≥35 years* 3. Pathologically diagnosed, by biopsy, with EOC prior to surgical intervention or treatment 4. Presenting with adnexal mass suspicious of OC on imaging and scheduled for surgical resection or biopsy (and subsequent confirmation of EOC) 5. Able to give informed consent Healthy controls 1. Women, trans men and non-binary people with female reproductive organs 2. Aged ≥35 years 3. No cancer history 4. Able to give informed consent
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.